Capstar Special Purpose ...【CPSR】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

7.36

買値

売値

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

7.36

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and...

Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with...

Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions

With the prevalence of fad diets, food shaming and resulting guilt, leading health experts advise against villainizing specific food groups and moving to flexibility and...

Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

Plenity® is transforming weight management with a clinically proven approach made from naturally derived building blocks As Chief Nutrition Officer, Bauer will focus on educating healthcare...

Gelesis Receives $30 Million Plenity Order from Ro

Gelesis’ new commercial manufacturing facility is now producing Plenity® at large scale, enabling supply to meet the growing demand Gelesis announced today that leading U.S. direct-to-patient...

Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and...

Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors

Chief Scientific Officer Elaine Chiquette, Pharm.D., Named Among the Top 25 Women Leaders in Biotechnology Elizabeth Pash, MS, RD, LDN, Honored by Academy of Nutrition and Dietetics for...

Gelesis, a Consumer-Focused Biotherapeutics Company & the Maker of Plenity®, to Become a Publicly Traded Company via Merger ...

Building on the successful beta launch of its first product Plenity®, Gelesis aims to transform weight management. Gelesis developed a novel biomimetic therapeutic platform that has yielded...

Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report

Capstar Special Purpose Acquisition Corp. (NYSE:CPSR.U; CPSR; CPSR WS) (the “Company”) today announced that, as expected, on May 25, 2021 it received a notice from the New York Stock Exchange...

Capstar Special Purpose Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Capstar Special Purpose Acquisition Corp. (the “Company”), today announced the pricing of its initial public offering of 24,000,000 units at a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CPSR - Frequently Asked Questions (FAQ)

What is the current Capstar Special Purpose ... share price?

The current share price of Capstar Special Purpose ... is US$ 7.36

What is the 1 year trading range for Capstar Special Purpose ... share price?

Capstar Special Purpose ... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

銘柄コード	株価	出来高
SEMRSEMrush Holdings Inc	US$ 13.08 (13.74%)	5.23k
AMTDAMTD IDEA Group	US$ 1.15 (8.49%)	303
OPFIOppFi Inc	US$ 9.93 (6.89%)	62.11k
INVXInnovex International Inc	US$ 16.50 (6.59%)	5.12k
SREASempra	US$ 24.50 (6.11%)	500
RNRRenaissanceRe Holdings Ltd	US$ 221.8301 (-11.29%)	1.53k
QBTSD Wave Quantum Inc	US$ 5.25 (-9.01%)	4.18M
MSCStudio City International Holdings Limited	US$ 4.40 (-7.76%)	7.24k
KOREKORE Group Holdings Inc	US$ 1.80 (-7.22%)	882
IONQIonQ Inc	US$ 30.62 (-5.29%)	1.53M
ABEVAmbev SA	US$ 1.79 (0.56%)	8.04M
ITUBItau Unibanco Holding SA	US$ 5.03 (-0.20%)	6.24M
TEVATeva Pharmaceutical Industries Ltd	US$ 21.1699 (1.10%)	5.04M
KOCoca Cola Company	US$ 60.95 (-0.20%)	4.97M
QBTSD Wave Quantum Inc	US$ 5.25 (-9.01%)	4.18M

銘柄コード

株価

出来高

ABEVAmbev SA

US$ 1.79

(0.56%)

8.04M

ITUBItau Unibanco Holding SA

US$ 5.03

(-0.20%)

6.24M

TEVATeva Pharmaceutical Industries Ltd

US$ 21.1699

(1.10%)

5.04M

KOCoca Cola Company

US$ 60.95

(-0.20%)

4.97M

QBTSD Wave Quantum Inc

US$ 5.25

(-9.01%)

4.18M

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Capstar Special Purpose Acquisition Corp (CPSR)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

CPSR 最新ニュース

Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar

Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee

Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions

Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

Gelesis Receives $30 Million Plenity Order from Ro

Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors

Gelesis, a Consumer-Focused Biotherapeutics Company & the Maker of Plenity®, to Become a Publicly Traded Company via Merger ...

Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report

Capstar Special Purpose Acquisition Corp. Announces Pricing of Upsized $240 Million Initial Public Offering

CPSR - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Capstar Special Purpose Acquisition Corp (CPSR) 銘柄情報

Capstar Special Purpose Acquisition Corp (CPSR)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

CPSR 最新ニュース

CPSR - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS